These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 5249235)

  • 1. [On blood coagulation disorders during enzyme therapy of malignant tumors and hemoblastoses].
    Stier HW; Gallmeier WM; Schmidt CG
    Dtsch Med Wochenschr; 1969 Feb; 94(6):253-60. PubMed ID: 5249235
    [No Abstract]   [Full Text] [Related]  

  • 2. [Does asparaginase therapy lead to consumption coagulopathy?].
    Lechler E; Hirschmann WD; Gross R
    Verh Dtsch Ges Inn Med; 1969; 75():484-7. PubMed ID: 5275878
    [No Abstract]   [Full Text] [Related]  

  • 3. [Coagulation changes following injection of a purified contact activation product].
    Barth P; Czygan P; Zimmermann R
    Verh Dtsch Ges Inn Med; 1971; 77():1029-32. PubMed ID: 5155957
    [No Abstract]   [Full Text] [Related]  

  • 4. [Blood coagulation disorder due to asparaginase].
    De Rossi G; Conti G; DeLuca AM; Monarca B; Tribalto M
    Haematologica; 1971; 56(9):420-9. PubMed ID: 5004542
    [No Abstract]   [Full Text] [Related]  

  • 5. [Hemostatic disorders in the treatment of leukoblastosis with L-asparaginase (crasnitin)].
    Genova V
    Vutr Boles; 1973; 12(2):43-9. PubMed ID: 4268271
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of heparin and AMCA on coagulation and fibrinolysis in blood and lymph following massive haemorrhage in dogs.
    Leandoer L; Bergentz SE; Nilsson IM
    Acta Chir Scand; 1969; 135(1):1-6. PubMed ID: 5805939
    [No Abstract]   [Full Text] [Related]  

  • 7. [Consumption coagulopathy].
    Holzknecht F
    Dtsch Med Wochenschr; 1970 Jun; 95(23):1275-7. PubMed ID: 5419827
    [No Abstract]   [Full Text] [Related]  

  • 8. [L-asparaginase in the treatment of lymphoblastic leukemia in children].
    Bohlmann HG; Gallmeier WM; Göbel FJ; Stier HW
    Z Kinderheilkd; 1969; 107(2):107-14. PubMed ID: 5262681
    [No Abstract]   [Full Text] [Related]  

  • 9. Coagulation defects in acute promyelocytic leukemia.
    Rand JJ; Moloney WD; Sise HS
    Arch Intern Med; 1969 Jan; 123(1):39-47. PubMed ID: 5248747
    [No Abstract]   [Full Text] [Related]  

  • 10. Coagulation disorders in severely and critically injured patients.
    Avikainen V
    Ann Chir Gynaecol; 1977; 66(6):269-77. PubMed ID: 603216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. L-asparaginase-induced coagulopathy in children with acute lymphoblastic leukaemia.
    Miniero R; Saracco P; Einaudi S; Garofalo F; Lange MM; Madon E
    Drugs Exp Clin Res; 1987; 13(6):377-9. PubMed ID: 3477418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypofibrinogenemia and coagulation factor deficiencies with L-asparaginase treatment.
    Gralnick HR; Henderson E
    Cancer; 1971 Jun; 27(6):1313-20. PubMed ID: 5282618
    [No Abstract]   [Full Text] [Related]  

  • 13. L-asparaginase-induced coagulation abnormalities: report of a case.
    Hensley MF
    J Am Osteopath Assoc; 1983 May; 82(9):680-1. PubMed ID: 6575006
    [No Abstract]   [Full Text] [Related]  

  • 14. L-asparaginase: therapeutic and toxic effects in patients with neoplastic disease.
    Haskell CM; Canellos GP; Leventhal BG; Carbone PP; Block JB; Serpick AA; Selawry OS
    N Engl J Med; 1969 Nov; 281(19):1028-34. PubMed ID: 4898857
    [No Abstract]   [Full Text] [Related]  

  • 15. The hemorrhagic phenomena associated with green pit viper (Trimeresurus erythrurus and Trimeresurus popeorum) bites in children. A report of studies to elucidate their pathogenesis.
    Mitrakul C; Impun C
    Clin Pediatr (Phila); 1973 Apr; 12(4):215-8. PubMed ID: 4540743
    [No Abstract]   [Full Text] [Related]  

  • 16. [Coagulation and immunoprotein changes under L-asparaginase therapy].
    Lechler E; Schumacher K; Hirschmann WD
    Med Welt; 1971 Jan; 4():127-34. PubMed ID: 4100623
    [No Abstract]   [Full Text] [Related]  

  • 17. Blood coagulation changes under L-asparaginase therapy.
    Deutsch E; Fischer M; Frischauf H; Honetz N; Lechner K; Pesendorfer F; Stych H; Weissmann A
    Recent Results Cancer Res; 1970; 33():331-41. PubMed ID: 4262281
    [No Abstract]   [Full Text] [Related]  

  • 18. Coagulation changes induced by endotoxin and purified contact activation product.
    Barth P; Zimmermann R
    Thromb Diath Haemorrh; 1972 Oct; 28(2):280-8. PubMed ID: 4639660
    [No Abstract]   [Full Text] [Related]  

  • 19. L-asparaginase in the treatment of neoplastic diseases in children.
    Jaffe N; Traggis D; Das L; Moloney WC; Hann HW; Kim BS; Nair R
    Cancer Res; 1971 Jul; 31(7):942-9. PubMed ID: 4327086
    [No Abstract]   [Full Text] [Related]  

  • 20. Consumption--coagulopathy in Kasabach-Merritt syndrome.
    Rodríguez-Erdmann F; Murray JE; Moloney WC
    Trans Assoc Am Physicians; 1970; 83():168-75. PubMed ID: 5534090
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.